Cancer, Cardiovascular Complication, Immune Checkpoint Inhibitor, Immune-related Adverse Event
Conditions
Brief summary
Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.
Interventions
OTHERNo intervention for research purposes only
No intervention for research purposes only
Sponsors
Institut Mutualiste Montsouris
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major cardiovascular event | 12 months | Composite endpoint: acute coronary syndrome, myocarditis, pericarditis, heart failure, Taki Tsubo, ventricvular arrhymias |
Countries
France
Contacts
Primary ContactIsabelle Sauret
Backup ContactNathalie Bass
Outcome results
None listed